Growth Metrics

Summit Therapeutics (SMMT) Share-based Compensation (IS) (2016)

Historic Share-based Compensation (IS) for Summit Therapeutics (SMMT) over the last 1 years, with Q2 2016 value amounting to $5.8 million.